These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33195086)

  • 1. Unveiling Druggable Pockets by Site-Specific Protein Modification: Beyond Antibody-Drug Conjugates.
    Martínez DG; Hüttelmaier S; Bertoldo JB
    Front Chem; 2020; 8():586942. PubMed ID: 33195086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
    Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
    J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
    Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
    Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current methods for the synthesis of homogeneous antibody-drug conjugates.
    Sochaj AM; Świderska KW; Otlewski J
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development.
    Agarwal P; Bertozzi CR
    Bioconjug Chem; 2015 Feb; 26(2):176-92. PubMed ID: 25494884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxime/Hydrazone Conjugation at Histidine: Late-Stage Functionalization Approach of Unprotected Peptides.
    Noisier AFM; Gopalakrishnan R
    Methods Mol Biol; 2021; 2355():35-48. PubMed ID: 34386948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K; Ito Y
    Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttranslational Chemical Mutagenesis: To Reveal the Role of Noncatalytic Cysteine Residues in Pathogenic Bacterial Phosphatases.
    Bertoldo JB; Terenzi H; Hüttelmaier S; Bernardes GJL
    Biochemistry; 2018 Oct; 57(43):6144-6152. PubMed ID: 30280890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfide Modified IgG1: An Investigation of Biophysical Profile and Clinically Relevant Fc Interactions.
    Bahou C; Love EA; Leonard S; Spears RJ; Maruani A; Armour K; Baker JR; Chudasama V
    Bioconjug Chem; 2019 Apr; 30(4):1048-1054. PubMed ID: 30855134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.
    Singh SK; Luisi DL; Pak RH
    Pharm Res; 2015 Nov; 32(11):3541-71. PubMed ID: 25986175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of new chemical entities with decreased potential for adverse drug reactions.
    Park KB; Dalton-Brown E; Hirst C; Williams DP
    Eur J Pharmacol; 2006 Nov; 549(1-3):1-8. PubMed ID: 16979156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Journey for the Total Chemical Synthesis of a 53 kDa Protein.
    Sun H; Brik A
    Acc Chem Res; 2019 Dec; 52(12):3361-3371. PubMed ID: 31536331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody structural integrity of site-specific antibody-drug conjugates investigated by hydrogen/deuterium exchange mass spectrometry.
    Pan LY; Salas-Solano O; Valliere-Douglass JF
    Anal Chem; 2015 Jun; 87(11):5669-76. PubMed ID: 25938577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemo- and Regioselective Lysine Modification on Native Proteins.
    Matos MJ; Oliveira BL; Martínez-Sáez N; Guerreiro A; Cal PMSD; Bertoldo J; Maneiro M; Perkins E; Howard J; Deery MJ; Chalker JM; Corzana F; Jiménez-Osés G; Bernardes GJL
    J Am Chem Soc; 2018 Mar; 140(11):4004-4017. PubMed ID: 29473744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the Development of Site-Specific Antibody-Drug Conjugation.
    Zhou Q; Kim J
    Anticancer Agents Med Chem; 2015; 15(7):828-36. PubMed ID: 25731178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
    Mondal S; Thompson PR
    Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine Conjugation Methods for Protein Labelling.
    Alvarez Dorta D; Deniaud D; Mével M; Gouin SG
    Chemistry; 2020 Nov; 26(63):14257-14269. PubMed ID: 32538529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical Protein Modification through Cysteine.
    Gunnoo SB; Madder A
    Chembiochem; 2016 Apr; 17(7):529-53. PubMed ID: 26789551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of homogeneous antibody-drug conjugates using site-selective protein chemistry.
    Akkapeddi P; Azizi SA; Freedy AM; Cal PMSD; Gois PMP; Bernardes GJL
    Chem Sci; 2016 May; 7(5):2954-2963. PubMed ID: 29997785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Chemical Modification Using Highly Reactive Species and Spatial Control of Catalytic Reactions.
    Sato S
    Chem Pharm Bull (Tokyo); 2022; 70(2):95-105. PubMed ID: 35110442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.